Importantly, it was recently shown in the context of non-small cell lung cancer that constitutively active Nrf2 generates enhancers at gene loci that are not normally regulated following transient activation of Nrf2 under physiological conditions21. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.